| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy &Dev. Officer
1 company
Desai Veeral is a Chief Strategy &Dev. Officer at AGL. Recent filings cover 1 purchase and 17 sales.
Our model assigns Desai Veeral a strong insider score of 70/100, based on 16 past trades. Over a 12-month horizon, 62.5% of those trades were profitable, with an average 12-month return of +28.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 197,291 | $20.41 | $4,026,709.31 | -43.0% | -5.9% | +30.7% | |
| Sep 14, 2021 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 121,001 | $28.98 | $3,506,608.98 | -31.6% | -26.2% | -21.1% |